| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6247668 | Transplantation Proceedings | 2014 | 8 Pages |
Abstract
Bladder cancer occurred more commonly in kidney transplant recipients with a predominance of aggressive tumors and a high mortality. In patients with preexisting risk factors such as urologic abnormalities and cyclophosphamide exposure careful assessment before transplantation and vigilant monitoring posttransplantation with a low threshold for cystoscopy may improve outcomes.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
S. Medani, P. O'Kelly, K.M. O'Brien, P. Mohan, C. Magee, P. Conlon,